News
Moderna is seeking emergency use authorization from the FDA for its Covid-19 vaccine for children 6 months through 5 years of age.
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results